Pub Date : 2025-12-29DOI: 10.1080/13506129.2025.2606847
Natasha J Burke, Lisa M Mendelson, Tracy Joshi, Caryn Libbey, Eric J Burks, Tatiana Prokaeva, Brian Spencer, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala, Andrew Staron
Background: Congo red (CR) staining of surrogate tissues, such as the abdominal fat pad (FP) or bone marrow (BM), provides a minimally invasive approach to diagnosing systemic amyloidosis. This study evaluated the diagnostic yield of surrogate tissue biopsies across amyloidosis classes.
Methods: We retrospectively analyzed 4,027 patients with systemic amyloidosis (1968-2023) who underwent CR staining of FP aspirates (n = 3,873) and/or BM core biopsies (n = 2,598). Detection rates were compared by amyloidosis class and biopsy site.
Results: AL amyloidosis had the highest CR positivity rates (FP: 73%; BM: 53%), whereas ATTRwt amyloidosis had the lowest (FP: 22%; BM: 26%). CR positivity in BM was not exclusive to AL amyloidosis; 74 CR-positive BM biopsies were in non-AL cases. Among 2,213 patients with AL amyloidosis who underwent both FP and BM sampling, combined testing increased detection to 85% (40% positive in both; 32% FP-only; 13% BM-only). Higher CR positivity grades in FP aspirates correlated with shorter survival in AL amyloidosis but not in other amyloidosis classes.
Conclusions: The diagnostic yield of CR-stained surrogate tissue biopsies varies by amyloidosis class and biopsy site. In AL amyloidosis, combining FP and BM sampling enhances detection, and FP CR positivity grade offers prognostic insight.
{"title":"Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients.","authors":"Natasha J Burke, Lisa M Mendelson, Tracy Joshi, Caryn Libbey, Eric J Burks, Tatiana Prokaeva, Brian Spencer, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala, Andrew Staron","doi":"10.1080/13506129.2025.2606847","DOIUrl":"https://doi.org/10.1080/13506129.2025.2606847","url":null,"abstract":"<p><strong>Background: </strong>Congo red (CR) staining of surrogate tissues, such as the abdominal fat pad (FP) or bone marrow (BM), provides a minimally invasive approach to diagnosing systemic amyloidosis. This study evaluated the diagnostic yield of surrogate tissue biopsies across amyloidosis classes.</p><p><strong>Methods: </strong>We retrospectively analyzed 4,027 patients with systemic amyloidosis (1968-2023) who underwent CR staining of FP aspirates (<i>n</i> = 3,873) and/or BM core biopsies (<i>n</i> = 2,598). Detection rates were compared by amyloidosis class and biopsy site.</p><p><strong>Results: </strong>AL amyloidosis had the highest CR positivity rates (FP: 73%; BM: 53%), whereas ATTRwt amyloidosis had the lowest (FP: 22%; BM: 26%). CR positivity in BM was not exclusive to AL amyloidosis; 74 CR-positive BM biopsies were in non-AL cases. Among 2,213 patients with AL amyloidosis who underwent both FP and BM sampling, combined testing increased detection to 85% (40% positive in both; 32% FP-only; 13% BM-only). Higher CR positivity grades in FP aspirates correlated with shorter survival in AL amyloidosis but not in other amyloidosis classes.</p><p><strong>Conclusions: </strong>The diagnostic yield of CR-stained surrogate tissue biopsies varies by amyloidosis class and biopsy site. In AL amyloidosis, combining FP and BM sampling enhances detection, and FP CR positivity grade offers prognostic insight.</p>","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-9"},"PeriodicalIF":7.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-25DOI: 10.1080/13506129.2025.2605534
Peter May, Johannes Jung, Marion Högner, Florian Bassermann
Background: Predicting amyloidogenic risk of immunoglobulin light chains in amyloid light-chain (AL) amyloidosis is a major challenge, and existing computational models fail to generalize to new patient data.
Methods: We developed ALyzer3D.AI, a multi-modal deep learning architecture that integrates evolutionary features from the ESM-2 Protein Language Model, structural metrics from ColabFold and engineered biophysical features. Generalizability was evaluated on published and independent datasets, and model interpretability was assessed using IMGT-aligned SHapley Additive exPlanations (SHAP).
Results: While existing models dropped in performance on new data (accuracy 0.42-0.56), ALyzer3D.AI maintained an accuracy of 0.65 when trained and tested on the same datasets. A final model built on the full combined cohort of 5261 sequences achieved stable performance across repeated splits, with independent test AUC of 0.86 and accuracy of 0.84 at an optimized decision threshold. Performance arose from synergistic integration of PLM, structural and scalar features. PLM attributions were broadly distributed and slightly enriched in framework regions, whereas structural SHAP values were concentrated in CDRs and FR4. The most informative positions had intermediate sequence entropy.
Conclusions: ALyzer3D.AI provides a robust, interpretable tool for predicting light-chain amyloidogenicity that generalizes better to independent datasets than existing methods. It is publicly available via https://colab.research.google.com/github/pcmay/ALyzer3D.AI/blob/main/ALyzer3DAI.ipynb.
{"title":"ALyzer3D.AI: a more generalizable deep learning predictor of light chain amyloidogenicity powered by structural and evolutionary Artificial Intelligence.","authors":"Peter May, Johannes Jung, Marion Högner, Florian Bassermann","doi":"10.1080/13506129.2025.2605534","DOIUrl":"https://doi.org/10.1080/13506129.2025.2605534","url":null,"abstract":"<p><strong>Background: </strong>Predicting amyloidogenic risk of immunoglobulin light chains in amyloid light-chain (AL) amyloidosis is a major challenge, and existing computational models fail to generalize to new patient data.</p><p><strong>Methods: </strong>We developed ALyzer3D.AI, a multi-modal deep learning architecture that integrates evolutionary features from the ESM-2 Protein Language Model, structural metrics from ColabFold and engineered biophysical features. Generalizability was evaluated on published and independent datasets, and model interpretability was assessed using IMGT-aligned SHapley Additive exPlanations (SHAP).</p><p><strong>Results: </strong>While existing models dropped in performance on new data (accuracy 0.42-0.56), ALyzer3D.AI maintained an accuracy of 0.65 when trained and tested on the same datasets. A final model built on the full combined cohort of 5261 sequences achieved stable performance across repeated splits, with independent test AUC of 0.86 and accuracy of 0.84 at an optimized decision threshold. Performance arose from synergistic integration of PLM, structural and scalar features. PLM attributions were broadly distributed and slightly enriched in framework regions, whereas structural SHAP values were concentrated in CDRs and FR4. The most informative positions had intermediate sequence entropy.</p><p><strong>Conclusions: </strong>ALyzer3D.AI provides a robust, interpretable tool for predicting light-chain amyloidogenicity that generalizes better to independent datasets than existing methods. It is publicly available <i>via</i> https://colab.research.google.com/github/pcmay/ALyzer3D.AI/blob/main/ALyzer3DAI.ipynb.</p>","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-13"},"PeriodicalIF":7.4,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-21DOI: 10.1080/13506129.2025.2605332
Luca Broggini, Diane Marie Valérie Bonnet, Karolina W Swiderska, Sebastien Bender, Gilles R Codo, Alessio Lampis, Gemma Martinez-Rivas, Pauline Duchatelet, Aurore Danigo, Antonio Chaves-Sanjuan, Christophe Sirac, Stefano Ricagno
{"title":"Untwisted amyloid fibrils from a transgenic mouse model of AL amyloidosis.","authors":"Luca Broggini, Diane Marie Valérie Bonnet, Karolina W Swiderska, Sebastien Bender, Gilles R Codo, Alessio Lampis, Gemma Martinez-Rivas, Pauline Duchatelet, Aurore Danigo, Antonio Chaves-Sanjuan, Christophe Sirac, Stefano Ricagno","doi":"10.1080/13506129.2025.2605332","DOIUrl":"https://doi.org/10.1080/13506129.2025.2605332","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-4"},"PeriodicalIF":7.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Endothelial glycocalyx disruption and early renal tubular injury in hereditary transthyretin Amyloidosis with dysautonomia.","authors":"Lara Albuquerque de Brito, Cleonisio Leite Rodrigues, Alexandre Braga Libório, Raynrich Kevin Assis Lima, Hermany Capistrano Freitas, Fernanda Martins Maia Carvalho","doi":"10.1080/13506129.2025.2603258","DOIUrl":"https://doi.org/10.1080/13506129.2025.2603258","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-4"},"PeriodicalIF":7.4,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Frontline Dara-CyBorD for AL amyloidosis: high response rates and cytogenetic insights from a real-world cohort.","authors":"Xia Wu, Eugène Brailovski, Denis Toskic, Stephanie Scalia, Ping Zhou, Xun Ma, Vasil Mico, Teresa Fogaren, Nancy Coady Lyons, Heather Landau, Raymond Comenzo","doi":"10.1080/13506129.2025.2592628","DOIUrl":"https://doi.org/10.1080/13506129.2025.2592628","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-4"},"PeriodicalIF":7.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-26DOI: 10.1080/13506129.2025.2562864
Carolina Lemos, Ersilia M DeFilippis
{"title":"Looking beyond left ventricular wall thickness: the search for cardiac amyloidosis in women.","authors":"Carolina Lemos, Ersilia M DeFilippis","doi":"10.1080/13506129.2025.2562864","DOIUrl":"10.1080/13506129.2025.2562864","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"309-310"},"PeriodicalIF":7.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145151606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-10-16DOI: 10.1080/13506129.2025.2570096
Vaishali Sanchorawala, Ashutosh Wechalekar, Peter Mollee, Yoshiki Sekijima, Mathew S Maurer, Nelson Leung, Stefan O Schönland, Shaji Kumar
{"title":"A collaborative approach to amyloidosis and a multidisciplinary care framework - position statement from the International Society of Amyloidosis.","authors":"Vaishali Sanchorawala, Ashutosh Wechalekar, Peter Mollee, Yoshiki Sekijima, Mathew S Maurer, Nelson Leung, Stefan O Schönland, Shaji Kumar","doi":"10.1080/13506129.2025.2570096","DOIUrl":"10.1080/13506129.2025.2570096","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"303-308"},"PeriodicalIF":7.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-10-15DOI: 10.1080/13506129.2025.2574101
Shaji Kumar
{"title":"Change of guard at <i>Amyloid</i> - a tribute to outgoing Editor in Chief, Professor Per Westermark.","authors":"Shaji Kumar","doi":"10.1080/13506129.2025.2574101","DOIUrl":"10.1080/13506129.2025.2574101","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"301-302"},"PeriodicalIF":7.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-15DOI: 10.1080/13506129.2025.2577796
Marta Domínguez-Martínez, Alfonso Caro-Llopis, Carmen Orellana
{"title":"Commentary to revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focus.","authors":"Marta Domínguez-Martínez, Alfonso Caro-Llopis, Carmen Orellana","doi":"10.1080/13506129.2025.2577796","DOIUrl":"10.1080/13506129.2025.2577796","url":null,"abstract":"","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"387-389"},"PeriodicalIF":7.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-07DOI: 10.1080/13506129.2025.2527830
Marta Domínguez-Martínez, Alfonso Caro-Llopis, Carla Martín-Grau, Mónica Roselló, Silvestre Oltra, Laia Pedrola, Sandra Monfort, Alba Gabaldón-Albero, Francisco Martínez, Carmen Orellana
Background: Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive disorder caused by TTR gene variants, leading to amyloid fibril deposition and clinical manifestations like cardiomyopathy and polyneuropathy. National data for Spain are scarce, despite known high-prevalence areas such as Majorca.
Methods: This multicentric, retrospective study analysed 4,526 individuals from 48/52 Spanish regions between 2015 and 2024, including 3,960 index cases and 566 at-risk relatives. Genetic testing was performed to identify pathogenic TTR variants.
Results: Among 393 carriers of pathogenic variants, the most prevalent were p.Val50Met (64.1%) and p.Val142Ile (29.5%). Regional prevalence varied, with new high-prevalence areas identified, including Cádiz, Castellón, Ciudad Real, Huelva, Valencia and Zamora. A novel variant of unknown clinical significance, p.Ser137Thr, was found in two unrelated cases. Genotype-phenotype correlations showed p.Val50Met is linked to neurological phenotypes, while p.Val142Ile is associated with cardiac manifestations. A male predominance was observed in index cases, while the sex ratio in carrier relatives was similar to the general population.
Conclusions: This is the largest nationwide study of ATTRv in Spain, providing key insights into its genetic landscape. The findings suggest migratory factors may influence variant distribution, emphasising the importance of genetic screening for early diagnosis and management.
{"title":"Genetic landscape of hereditary transthyretin amyloidosis in Spain: a multicentric retrospective study.","authors":"Marta Domínguez-Martínez, Alfonso Caro-Llopis, Carla Martín-Grau, Mónica Roselló, Silvestre Oltra, Laia Pedrola, Sandra Monfort, Alba Gabaldón-Albero, Francisco Martínez, Carmen Orellana","doi":"10.1080/13506129.2025.2527830","DOIUrl":"10.1080/13506129.2025.2527830","url":null,"abstract":"<p><strong>Background: </strong>Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive disorder caused by <i>TTR</i> gene variants, leading to amyloid fibril deposition and clinical manifestations like cardiomyopathy and polyneuropathy. National data for Spain are scarce, despite known high-prevalence areas such as Majorca.</p><p><strong>Methods: </strong>This multicentric, retrospective study analysed 4,526 individuals from 48/52 Spanish regions between 2015 and 2024, including 3,960 index cases and 566 at-risk relatives. Genetic testing was performed to identify pathogenic <i>TTR</i> variants.</p><p><strong>Results: </strong>Among 393 carriers of pathogenic variants, the most prevalent were p.Val50Met (64.1%) and p.Val142Ile (29.5%). Regional prevalence varied, with new high-prevalence areas identified, including Cádiz, Castellón, Ciudad Real, Huelva, Valencia and Zamora. A novel variant of unknown clinical significance, p.Ser137Thr, was found in two unrelated cases. Genotype-phenotype correlations showed p.Val50Met is linked to neurological phenotypes, while p.Val142Ile is associated with cardiac manifestations. A male predominance was observed in index cases, while the sex ratio in carrier relatives was similar to the general population.</p><p><strong>Conclusions: </strong>This is the largest nationwide study of ATTRv in Spain, providing key insights into its genetic landscape. The findings suggest migratory factors may influence variant distribution, emphasising the importance of genetic screening for early diagnosis and management.</p>","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"324-334"},"PeriodicalIF":7.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}